U.S. Pharma Stock News

NasdaqGS:PFG
NasdaqGS:PFGInsurance

Should Rising Earnings Expectations And Dividend Appeal Require Action From Principal Financial Group (PFG) Investors?

In the lead-up to its recent earnings report, Principal Financial Group drew attention as analysts anticipated year-over-year increases in earnings and revenue, supported by growth in Fees, Net Investment Income, and Premiums. At the same time, investors have been weighing mixed valuation models against Principal’s higher-than-industry dividend yield and history of dividend increases, which some see as a key attraction. Against this backdrop of rising earnings expectations and dividend...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

CSX (CSX) After Earnings And Guidance Update, Is The Valuation Story Too Full?

CSX (CSX) is back in focus after releasing second quarter 2026 results, updating its full year guidance and detailing recent buybacks and dividend plans, giving investors fresh information to assess the stock. See our latest analysis for CSX. CSX shares have been climbing, with a 30 day share price return of 11.69% and a year to date share price return of 46.76%. The 1 year total shareholder return of 50.96% points to strong momentum building around the stock. If the recent move in CSX has...
NYSE:TPC
NYSE:TPCConstruction

Tutor Perini Stock And 2 Industrial Picks For U.S. Reshoring Demand

With the Trump administration rolling out a fresh wave of 10% to 12.5% global tariffs on 60 countries, nearly every imported product into the U.S. now carries an extra cost. That kind of broad trade friction can punish some business models and create room for others that help companies rethink where and how they operate. This article looks at 3 stocks exposed to the tariff news through their roles in logistics, automation, and supply chain support. It is intended to help you consider whether...
NYSE:AGCO
NYSE:AGCOMachinery

AGCO (AGCO) Stock May Be Below Fair Value On Precision Farming News

AGCO stock has gained 14.5% year to date, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount to what the underlying business may justify. Year to date, AGCO is up 14.5%, which puts recent returns into positive territory while still leaving room for a potential valuation gap. Attention on agricultural machinery components and precision farming, including AGCO's involvement in brand agnostic precision...
NYSE:IRM
NYSE:IRMSpecialized REITs

Iron Mountain (IRM) Has Strong Long Term Momentum, Is A 26% Discount Still Real?

Iron Mountain stock in focus after recent performance shift Iron Mountain (IRM) is drawing attention after a mixed stretch in its share performance, with the stock up over the past 3 months but down over the past month, prompting fresh questions about valuation. See our latest analysis for Iron Mountain. At the latest share price of $128.31, Iron Mountain has seen strong momentum over the year, with a year to date share price return of 54.14% and a 1 year total shareholder return of 33.56%...
NasdaqGS:KMTS
NasdaqGS:KMTSMedical Equipment

Kestra Medical Technologies (KMTS) Secures $200 Million Debt Facility Without New Equity

Kestra Medical Technologies (NasdaqGS:KMTS) arranged a $200 million non-dilutive five year term loan facility. The financing includes new lending partnerships with BPCR Limited Partnership and BioPharma Credit Investments V. The company refinanced and retired existing debt as part of the transaction, while maintaining a solid cash position. Kestra Medical Technologies enters this financing with a mixed recent share price record. The stock is up 27.3% over the past year, while down 13.8%...
NYSE:GS
NYSE:GSCapital Markets

Is Goldman Sachs’ Private Markets and Hedging Expansion Altering The Investment Case For Goldman Sachs Group (GS)?

Goldman Sachs Group has recently launched a new private markets platform for wealthy clients and agreed to acquire AEGIS Hedging Solutions, while also issuing a wide range of new fixed and variable-rate notes across multiple currencies and maturities. Together with stronger second-quarter results, a large share repurchase program, and new preferred and long-dated funding, these moves highlight Goldman’s push to deepen fee-based wealth relationships and diversify its capital and...
NYSE:ADC
NYSE:ADCRetail REITs

Does Agree Realty's Higher 2026 Dividend Payout Reveal a Deeper Capital Allocation Shift for ADC?

Agree Realty Corporation recently declared a monthly cash dividend of US$0.267 per common share and US$0.08854 per 4.25% Series A preferred depositary share, with both payouts scheduled for August 2026 to shareholders of record in late July 2026. The common dividend represents a 4.3% annualized increase from the third quarter of 2025 rate, underscoring the REIT’s emphasis on returning cash to shareholders across both its common and preferred capital structure. Next, we’ll examine how this...
NYSE:MMM
NYSE:MMMIndustrials

Is 3M (MMM) Fairly Valued As Strong Q2 Earnings Lift Its Outlook?

Why 3M Stock Is Back in Focus After Its Second Quarter Update 3M (MMM) has moved back onto investors’ radar after reporting second quarter earnings that outpaced expectations, raising its full year profit forecast and drawing favorable attention from both Wall Street analysts and high profile commentators. See our latest analysis for 3M. 3M’s recent earnings beat, higher profit guidance and AI focused partnership with Microsoft have coincided with an 18.42% 90 day share price return and a...
NYSE:STT
NYSE:STTCapital Markets

Earnings Beat, Higher Payouts and Completed Buyback Could Be A Game Changer For State Street (STT)

State Street Corporation has reported past second-quarter 2026 results showing net income of US$1.08 billion and diluted earnings per share from continuing operations of US$3.65, alongside declaring higher common and preferred dividends and confirming completion of a US$2.90 billion buyback that retired 10.25% of its shares since early 2024. The combination of stronger earnings, a richer cash return profile and a fully executed multi‑year repurchase program underscores how management is...
NYSE:REZI
NYSE:REZIBuilding

Is Resideo Technologies (REZI) Undervalued After Fresh Optimism Over Another Earnings Beat?

Resideo Technologies (REZI) has drawn fresh attention after recent coverage highlighted its history of topping earnings estimates, with analysts increasingly expecting another potential beat that could keep investor sentiment focused on upcoming results. See our latest analysis for Resideo Technologies. Recent optimism around Resideo Technologies’ earnings record comes after a mixed price pattern, with the share price up 11.56% over the past month but down 14.72% over the past quarter, while...
NYSE:CXM
NYSE:CXMSoftware

AI Stocks Small Businesses Are Driving Higher In 2026

Artificial intelligence is no longer just a big tech story, it is filtering into everyday small business tools, from customer support to scheduling and marketing. As small businesses adopt AI to boost productivity and support existing staff, rather than replace them, certain AI software and services stocks could see new demand, while others may face slower uptake where data privacy or reliability concerns are front of mind. This article looks at how that news backdrop connects to the AI...
NasdaqGS:AVAV
NasdaqGS:AVAVAerospace & Defense

AeroVironment (AVAV) Gains Italian MQ 31A Recognition, Is It Still 41% Undervalued?

AeroVironment (AVAV) is back in focus after Italy’s Directorate of Aeronautical Armaments and Airworthiness granted the MQ-31A military designation to its JUMP 20 unmanned aircraft system for the Italian Army. See our latest analysis for AeroVironment. AeroVironment’s recent MQ-31A milestone comes after a mixed share price pattern, with the stock falling 41.64% year to date on a share price basis but still delivering a 57.33% total shareholder return over three years. Recent momentum has...
NYSE:KN
NYSE:KNElectronic

Knowles (KN) Lifted Guidance, Is The Stock Now Fully Valued?

Knowles (KN) drew investor attention after reporting fiscal Q2 2026 results above its prior guidance and lifting full year revenue and earnings forecasts, supported by strength in Precision Devices and MedTech & Specialty Audio. See our latest analysis for Knowles. Despite the post earnings pullback, with a 1 day share price return down 3.2%, Knowles has strong momentum in the background, with a year to date share price return of 71.2% and a 1 year total shareholder return of 84.3%. If strong...
NasdaqGS:HAS
NasdaqGS:HASLeisure

Hasbro (HAS) Is Up 8.9% After Q2 Profit Rebound And Fresh Franchise Push At Comic-Con

Hasbro, Inc. reported second-quarter 2026 sales of US$1,139.6 million and net income of US$160.9 million, reversing a very large prior-year loss, while also affirming a quarterly dividend of US$0.70 per share. Alongside these stronger results, Hasbro highlighted fresh content and collectibles across franchises like Star Wars, My Little Pony, Ghostbusters, and KPop Demon Hunters, underscoring how its entertainment pipeline and licensed IP continue to underpin its toy and gaming...
NYSE:FNF
NYSE:FNFInsurance

Should Fidelity National Financial’s Latest Segment Mix Shift on Q2 2026 Call Matter to FNF Investors?

Fidelity National Financial recently reported its second quarter 2026 results and held an earnings conference call, updating the market on performance across its Title, F&G, and Corporate and Other segments. This earnings update offers investors a fresh read on how the company’s diversified title and insurance operations are balancing costs, digital investment, and segment mix. Now we’ll explore how the latest quarterly earnings call reframes Fidelity National Financial’s investment...
NYSE:BR
NYSE:BRProfessional Services

Is Broadridge Financial Solutions (BR) Undervalued As AI And Tokenization Risks Test Sentiment?

Recent commentary on Broadridge Financial Solutions (BR) has focused on execution risk, as investors evaluate how AI tools and tokenized assets could affect the company’s established technology and governance services. See our latest analysis for Broadridge Financial Solutions. Beneath the recent headlines around AI disruption and tokenized assets, Broadridge Financial Solutions’ share price has been volatile, with a 3.13% 1 day share price return and a 7.97% 30 day share price return, but a...
NYSE:ACN
NYSE:ACNIT

Accenture Stock Leads 3 Dividend Picks For Steady Income

With energy markets, inflation paths and central bank decisions all pulling asset prices in different directions, many investors are looking for a steadier source of cash flow from their portfolios. Dividend Powerhouses, companies offering yields above 5% that are well covered, growing and stable, can help add that kind of consistency when headlines are noisy and growth signals are mixed across regions. This article looks at three stocks from the Dividend Powerhouses screener that are notable...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Luckin Coffee (OTCPK:LKNC.Y) Stock Looks Undervalued Despite A 163% Five Year Return

Luckin Coffee stock has returned about 162.7% over the past five years, yet its broader valuation checks still indicate the shares screen as cheap relative to fundamentals, which puts recent weakness this year in a different light for investors trying to judge value today. Over five years, a 162.7% return suggests Luckin Coffee has already rewarded patient shareholders, so the key issue now is whether the current price still offers an attractive entry point for new capital. The push into New...
NYSE:FHI
NYSE:FHICapital Markets

Federated Hermes (FHI) Could Be 16% Undervalued On HR Leadership Change

Federated Hermes (FHI) has appointed Kimberly Craver as Head of Global Human Resources, taking over from long serving HR leader Dolores Dudiak, an event that puts internal capabilities and leadership succession in focus for investors. See our latest analysis for Federated Hermes. Federated Hermes shares trade at US$57.92, with a 1-day share price return of 1.06% and year to date share price return of 10.60%. The 1-year total shareholder return of 20.78% and 5-year total shareholder return of...
NasdaqGS:QRVO
NasdaqGS:QRVOSemiconductor

Qorvo (QRVO) Stock Looks Close To Fair Value Today

Qorvo stock has been roughly flat over the past year but has declined sharply over five years, and the latest valuation work suggests the current share price sits close to its estimated intrinsic value rather than at a clear discount or premium. Qorvo shareholders have seen the stock decline about 54% over the past 5 years, which puts the recent share price in the context of a long period of weak returns. The new distribution agreement with Rochester Electronics can support long term demand...
NYSE:CNP
NYSE:CNPIntegrated Utilities

CenterPoint Energy (CNP) Raises Dividend As Its Slight Undervaluation Comes Into Question

CenterPoint Energy (CNP) drew fresh attention after its board approved a higher quarterly cash dividend of $0.24 per share, a $0.01 raise compared with April, payable on September 10 to shareholders of record as of August 20. See our latest analysis for CenterPoint Energy. At a share price of $44.56, CenterPoint Energy has a 1-day share price return of 0.75% and a year to date share price return of 15.05%. The 5-year total shareholder return of 98.57% points to strong long term compounding,...
NYSE:KO
NYSE:KOBeverage

Coca Cola (KO) Valuation In Focus Following Dividend Reaffirmation And Earnings Optimism

Coca-Cola (KO) has reaffirmed its regular quarterly dividend at US$0.53 per common share, payable on October 1, 2026, to shareholders of record as of September 15, keeping income firmly in focus. See our latest analysis for Coca-Cola. Alongside the reaffirmed dividend, Coca-Cola’s recent price action has been positive. The share price is at US$82.25 and a 90-day share price return of 9.03% has contributed to a year-to-date share price return of 19.00%, while the 1-year total shareholder...
NasdaqGS:ERAS
NasdaqGS:ERASBiotechs

Does Litigation Over ERAS-0015 and Big Capital Raise Reshape The Bull Case For Erasca (ERAS)?

Earlier in July 2026, Erasca reported updated preliminary Phase 1 data showing generally well-tolerated monotherapy and promising combination potential for its investigational pan-RAS molecular glue ERAS-0015 in RAS-mutant solid tumors, while also raising approximately US$550.00 million through a follow-on common stock offering and filing an omnibus shelf registration. At the same time, multiple securities class actions and investigations emerged alleging patent infringement, trade secret...